Concurrent Session 4A: Harm Reduction, Overdose & Drug Use Practices
Tracks
.
| Wednesday, November 11, 2026 |
| 9:00 AM - 10:30 AM |
| Pleiades |
Speaker
Mr Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA
Introduction & Welcome
9:00 AM - 9:05 AM
Paul is CEO of Peer Based Harm Reduction WA (PBHR WA), Western Australia’s only peer-based consumer-led AOD service, which provides free health and harm reduction services for people who use drugs. Paul has worked at PBHR WA for >25 years, delivering and coordinating outreach services, overdose prevention, take-home-naloxone, and peer-education projects, while providing consultancy to researchers and policy makers and workforce development to other front-line agencies. Paul has previously worked as a Drug & Alcohol Officer for the State-wide Specialist Aboriginal Mental Health Service; an educator & consultant for the Transnational Institute (in China and Myanmar); and a trainer for the Burnet Institute. Paul is committed to addressing stigmatisation directed at, improving the health equity of, and promoting the fundamental human rights of, people who use drugs. In all his work Paul strives to bring the voices and living experience of people who use drugs to research, policy, and practice.
A/Prof Thileepan Naren
Addiction Medicine Specialist
Western Health
Mobilising Harm Reduction services to adapt to changing population
9:05 AM - 9:15 AM
A/Prof Thileepan Naren is an Addiction Medicine Specialist and General Practitioner and has special interests in addiction medicine, Aboriginal health, custodial health, public health policy, and medical governance.
Dr Jodie Grigg
Research Fellow
National Drug Research Institute, Curtin University
Patterns of polysubstance use during stimulant consumption sessions and self-reported non-fatal overdose events among people who regularly use ecstasy and other illicit stimulants in Australia
9:15 AM - 9:25 AM
Jodie is a Postdoctoral Research Fellow at NDRI where she is the long-standing coordinator of the Perth arm of the Ecstasy and Related Drugs Reporting System (EDRS). She has a strong interest in monitoring polysubstance use trends, drug-related harms, and harm reduction, particularly in music and event settings.
A/Prof Daniel Demant
Associate Professor in Social Epidemiology
Discipline of Public Health, University Of Technology Sydney
Understanding chemsex beyond risk: Psychosocial correlates and substance use patterns in Australia
9:25 AM - 9:35 AM
Daniel Demant is an Associate Professor of social epidemiology with a focuses substance use and sexual wellbeing, particularly in LGBTQ+ populations. His work aims at exploring the psychosocial and contextual drivers of risk and harm and the relationship between substance use and sexual wellbeing.
Miss Grace Oh
Director
Australian Drug Education & Consultancy
Co-presenter: Innovative Harm Reduction: Disrupting the Homelessness Merry-Go-Round - Transitional Housing with Integrated Drug and Alcohol Treatment
9:35 AM - 9:45 AM
Grace Oh, AOD harm reductionist, is known for her optimism and commitment to advocacy and advancing equitable, person-centred initiatives across drug checking, naloxone, peer education, and treatment for people facing recurring homelessness. She is a Director of Australian Drug Education & Consultancy and WA APSAD Council representative.
Dr Courtney Weber
Data Manager For The Emerging Drugs Network Of Australia
Royal Perth Hospital
3,4-methylenedioxymethylamphetamine (MDMA) concentrations in Emergency Department presentations enrolled in the Emerging Drugs Network of Australia
9:45 AM - 9:55 AM
Courtney Weber is the Data Manager for the Emerging Drugs Network of Australia. Her interests are novel psychoactive substances and epidemiological methods.
Dr Louisa Picco
Senior Research Fellow
Monash Addiction Research Centre, Monash University
Changes in naloxone attitudes and provision over the past decade: Findings from the National Drug Strategy Household Surveys and national community pharmacy surveys
9:55 AM - 10:05 AM
Dr Louisa Picco is an NHMRC Emerging Leader Research Fellow and the Drug Policy and Harm Reduction Program Lead at the Monash Addiction Research Centre. Her work adopts a multifaceted approach to explore the implementation and impact of opioid policies and harm reduction strategies.
Dr Hayden Green
GP and Addiction Medicine Trainee
Cohealth
Dr Kirrilly Thompson
Senior Research Fellow
NCETA
Barriers and enablers to take-home naloxone access in Australia: A scoping review
10:10 AM - 10:15 AM
Clinical pharmacy postdoctoral research fellow with expertise in medication use, cardiac rehabilitation, pharmacotherapy, and adherence. Holds a PhD in Clinical Pharmacy and has over 10 years’ experience across research, academia, and pharmacy practice in Australia and Ethiopia, with more than 25 peer-reviewed publications and multidisciplinary collaborations.
APSAD 2026
Session Q&A
10:15 AM - 10:30 AMChair
Paul Dessauer
Chief Executive Officer
Peer Based Harm Reduction WA